Cardiovascular Risk in Childrens with Chronic Conditions Study

Unique Identifier: 
CR3C
Open for Collab.: 
YES
Study Type: 
Cohort
Description: 
Children living with chronic health conditions face a higher risk of developing cardiovascular diseases than their peers, largely due to the accelerated aging of the heart and blood vessels. Although experts recognize this elevated risk and recommend close monitoring and early intervention, the underlying mechanisms driving this phenomenon remain poorly understood. At present, no effective interventions specifically target its root causes. Recent research shows that both large blood vessels (such as the carotid artery) and small vessels (such as those in the retina) can display early signs of damage decades before clinically apparent heart or vascular disease emerges. This accelerated vascular aging can result from multiple factors - including disease-related processes such as persistent inflammation and metabolic disturbances, treatment-related effects such as chemotherapy or long-term steroid use, and lifestyle changes associated with chronic illness, such as reduced physical activity and altered eating habits. However, it is still unclear how these factors influence the development and progression of vascular changes in children as they grow. Importantly, these changes can be monitored through non-invasive methods, offering a unique opportunity to study at-risk patients many years before overt cardiovascular disease develops. Identifying these early changes may enable us to detect and track individuals at heightened risk well in advance of clinical disease. This study aims to deepen our understanding of the causes of increased cardiovascular risk in children with chronic conditions and to lay the groundwork for earlier, more targeted prevention strategies.
Principal Investigator: 

Kiss Tamás

Semmelweis University
Contact Person: 

Kiss Tamás

Semmelweis University

Cohort Institutions

Institute Address ZIP Code City Country ⚙
Semmelweis University Üllői út 26. 1085 Budapest Hungary

Cohort Drugs



No Record Found.


Cohort Diseases



No Record Found.


Cohort Variables



No Record Found.


Cohort Publications



No Record Found.


Cohort Populations

Name Size Sex Min. Age Max. Age Inclusion Criteria Exclusion Criteria ⚙
Population (size: 300 , Both , Age: 6-25)-ID: 300 Both 6 25 Children, adolescents, and young adults (aged 6-25 years) who have been diagnosed with a chronic childhood condition associated with an increased risk of early-onset cardiovascular disease, and who are receiving care at a university-affiliated clinical setting. Participants must be capable of providing informed consent (if ≥18 years old) or have consent provided by a legal guardian (if <18 years old). The population excludes individuals with severe intellectual disabilities, decompensated heart failure, severe primary immunodeficiencies, active intravenous chemotherapy, communicable diseases that pose a public health risk, or a history of regular alcohol or drug use.

Cohort Samples

Quantity Sample Type Sharable Sample Diseases Omics Tests ⚙
30 Blood serum NO View
30 EDTA plasma NO View